Application Information

This drug has been submitted to the FDA under the reference 205437/001.

Names and composition

"OTEZLA" is the commercial name of a drug composed of APREMILAST.
It belongs to the class PDE4 inhibitors and is used in Rheumatoid arthritis, other autoimmune disorders (Musculoskeletal Disorders)

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
205437/001 OTEZLA APREMILAST TABLET/ORAL 10MG
205437/002 OTEZLA APREMILAST TABLET/ORAL 20MG
205437/003 OTEZLA APREMILAST TABLET/ORAL 30MG
206088/001 OTEZLA APREMILAST TABLET/ORAL 10MG
206088/002 OTEZLA APREMILAST TABLET/ORAL 20MG
206088/003 OTEZLA APREMILAST TABLET/ORAL 30MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
205437/001 OTEZLA APREMILAST TABLET/ORAL 10MG
205437/002 OTEZLA APREMILAST TABLET/ORAL 20MG
205437/003 OTEZLA APREMILAST TABLET/ORAL 30MG
206088/001 OTEZLA APREMILAST TABLET/ORAL 10MG
206088/002 OTEZLA APREMILAST TABLET/ORAL 20MG
206088/003 OTEZLA APREMILAST TABLET/ORAL 30MG

Manufacturers

Manufacturer name
Celgene Ltd

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved